Medpace Holdings Market capitalization 2024

The Medpace Holdings Market capitalization history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)	NET INCOME (undefined USD)
2029e	4.06	12,91	689.19
2028e	3.67	14,29	611.45
2027e	3.25	16,14	540.99
2026e	2.94	17,82	488.47
2025e	2.57	20,42	414.98
2024e	2.21	23,71	355.15
2023	1.89	27,81	282.62
2022	1.46	29,62	245.2
2021	1.14	28,73	181.4
2020	0.93	30,10	144.9
2019	0.86	28,54	100.2
2018	0.7	30,58	72.9
2017	0.44	40,05	39
2016	0.42	40,82	13.4
2015	0.36	43,55	-8.7
2014	0.33	40,96	-15.6
2013	0.27	45,62	24.8

Medpace Holdings Aktienanalyse

What does Medpace Holdings do?

The company Medpace Holdings Inc is a global company specializing in conducting clinical trials and providing R&D services in the pharmaceutical and biotech industry. Medpace was founded in 1992 by Dr. August Troendle and is headquartered in Cincinnati, Ohio. Medpace's business model is based on offering a variety of services to pharmaceutical and biotech companies as a contract research organization (CRO), ranging from planning and conducting clinical trials to their evaluation. This includes regulatory consulting services, project management and data management, as well as monitoring and quality assurance. Medpace specializes in conducting complex studies for testing and approval of new drugs or medical technology products. However, the company also has experience in conducting post-marketing studies and supporting products that are already established in the global markets. Medpace's various divisions cover a wide range of therapy areas, from oncology and cardiovascular diseases to rare diseases and infectious diseases. The company has worked in over 60 countries and has 35 offices worldwide, including in Europe, Asia, and South America. Medpace has earned a reputation as a trusted partner in the planning, conducting, and evaluation of clinical trials and works closely with clients to understand their needs and requirements. The company has extensive experience working with regulatory authorities around the world and supports its clients in compliance with applicable regulations and requirements. Medpace's product portfolio includes a wide range of services tailored to the individual needs of its clients. These include: - Clinical trial management: Medpace supports clients in all aspects of planning, conducting, and monitoring clinical trials, including budget, personnel, and resource management. - Data management: Medpace offers comprehensive data management solutions, including data capture, validation, and storage, as well as a web-based platform for real-time data retrieval. - Regulatory consulting: Medpace provides support in all aspects of regulatory requirements, from preparation and submission of regulatory applications to monitoring and maintaining approvals. - Medical monitoring: Medpace provides experienced medical personnel to monitor the safety of study participants and assist in the monitoring of adverse events and interpretation of medical data. - Quality management: Medpace has a comprehensive quality management system that ensures all clinical trials are conducted according to the highest quality standards. Over the years, Medpace has received numerous awards and recognitions and is valued by its clients for its high quality, flexibility, and innovation. The company is constantly striving to improve its services and processes to meet the changing needs of the industry. Medpace Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Medpace Holdings's Market Capitalization

Medpace Holdings's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Medpace Holdings's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Medpace Holdings's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Medpace Holdings’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Medpace Holdings Stock

What is the current Medpace Holdings market capitalization?

The current market capitalization of Medpace Holdings is 12.44 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Medpace Holdings.

How has the market capitalization of Medpace Holdings developed in recent years?

The market capitalization of Medpace Holdings has increased/decreased by 79.48% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Medpace Holdings?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Medpace Holdings?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Medpace Holdings have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Medpace Holdings pay?

Over the past 12 months, Medpace Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medpace Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Medpace Holdings?

The current dividend yield of Medpace Holdings is .

When does Medpace Holdings pay dividends?

Medpace Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medpace Holdings?

Medpace Holdings paid dividends every year for the past 0 years.

What is the dividend of Medpace Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medpace Holdings located?

Medpace Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medpace Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medpace Holdings from 5/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/25/2024.

When did Medpace Holdings pay the last dividend?

The last dividend was paid out on 5/25/2024.

What was the dividend of Medpace Holdings in the year 2023?

In the year 2023, Medpace Holdings distributed 0 USD as dividends.

In which currency does Medpace Holdings pay out the dividend?

The dividends of Medpace Holdings are distributed in USD.